Phytochemical and Cytotoxic Aspects of Amaryllidaceae Alkaloids in Species: A Review

Overview

Journal Plants (Basel)

Date 2025 Jan 8

PMID 39771275

Authors

Borislav Georgiev

Boriana Sidjimova

Strahil Berkov

Affiliations

Soon will be listed here.

Abstract

The genus (Amaryllidaceae) currently contains 25 plant species naturally occurring in Europe and the Middle East region. These perennial bulbous plants possess well-known medicinal and ornamental qualities. Alkaloid diversity is their most distinctive phytochemical feature. A total of 127 compounds (≈20% of all known Amaryllidaceae alkaloids) grouped in 16 structural types have been previously found in extracts. Some structural types like galanthindole, graciline and plicamine were first discovered in plants. Nine species, however, remain unstudied regarding their alkaloid patterns. Intraspecific variability has only been studied in and . Amaryllidaceae alkaloids are molecules with anticholinesterase, antibacterial, antifungal, antiviral and anticancer properties. Galanthamine, isolated for the first time from Losinsk., stands out as an acetylcholinesterase inhibitor approved for medical use by the FDA for the treatment of symptoms of Alzheimer's disease. Lycorine, narciclasine and pancratistatin are noteworthy cytotoxic and antitumor alkaloids. Structural types like galanthamine, homolycorine and haemanthamine are fairly well studied in anticancer research, but little to no information is available on galanthindole, graciline and other types. This review aims to present an update on the alkaloid diversity of spp. and highlight the need for further research on the antitumor potential of these molecules.

References

Shen J, Ruan Y, Ren W, Ma B, Wang X, Zheng C . Lycorine: a potential broad-spectrum agent against crop pathogenic fungi. J Microbiol Biotechnol. 2013; 24(3):354-8. DOI: 10.4014/jmb.1310.10063. View

Stavrakov G, Philipova I, Lukarski A, Atanasova M, Zheleva D, Zhivkova Z . Galantamine-Curcumin Hybrids as Dual-Site Binding Acetylcholinesterase Inhibitors. Molecules. 2020; 25(15). PMC: 7435983. DOI: 10.3390/molecules25153341. View

Marco L, Carreiras M . Galanthamine, a natural product for the treatment of Alzheimer's disease. Recent Pat CNS Drug Discov. 2008; 1(1):105-11. DOI: 10.2174/157488906775245246. View

Breiterova K, Koutova D, Marikova J, Havelek R, Kunes J, Majorosova M . Amaryllidaceae Alkaloids of Different Structural Types from L. cv. Professor Einstein and Their Cytotoxic Activity. Plants (Basel). 2020; 9(2). PMC: 7076679. DOI: 10.3390/plants9020137. View

Emir A, Emir C, Bozkurt B, Unver Somer N . GC/MS Analysis of Alkaloids in Baker and Determination of Its Anticholinesterase Activity. Turk J Pharm Sci. 2020; 17(1):36-42. PMC: 7227861. DOI: 10.4274/tjps.galenos.2018.26056. View

colovic M, Krstic D, Lazarevic-Pasti T, Bondzic A, Vasic V . Acetylcholinesterase inhibitors: pharmacology and toxicology. Curr Neuropharmacol. 2013; 11(3):315-35. PMC: 3648782. DOI: 10.2174/1570159X11311030006. View

Evidente A, Kireev A, Jenkins A, Romero A, Steelant W, Van Slambrouck S . Biological evaluation of structurally diverse amaryllidaceae alkaloids and their synthetic derivatives: discovery of novel leads for anticancer drug design. Planta Med. 2009; 75(5):501-7. PMC: 3125136. DOI: 10.1055/s-0029-1185340. View

Le N, De Jonghe S, Erven K, Vermeyen T, Balde A, Herrebout W . Anti-SARS-CoV-2 Activity and Cytotoxicity of Amaryllidaceae Alkaloids from . Molecules. 2023; 28(7). PMC: 10096449. DOI: 10.3390/molecules28073222. View

Berkov S, Bastida J, Nikolova M, Viladomat F, Codina C . Rapid TLC/GC-MS identification of acetylcholinesterase inhibitors in alkaloid extracts. Phytochem Anal. 2008; 19(5):411-9. DOI: 10.1002/pca.1066. View

10.

Sun Q, Shen Y, Tian J, Tang J, Su J, Liu R . Chemical constituents of Crinum asiaticum L. var. sinicum Baker and their cytotoxic activities. Chem Biodivers. 2009; 6(10):1751-7. DOI: 10.1002/cbdv.200800273. View

11.

Cragg G, Pezzuto J . Natural Products as a Vital Source for the Discovery of Cancer Chemotherapeutic and Chemopreventive Agents. Med Princ Pract. 2015; 25 Suppl 2:41-59. PMC: 5588531. DOI: 10.1159/000443404. View

12.

Locarek M, Novakova J, Kloucek P, Hostalkovia A, Kokoska L, Lucie Gabrlova . Antifungal and Antibacterial Activity of Extracts and Alkaloids of Selected Amaryllidaceae Species. Nat Prod Commun. 2015; 10(9):1537-40. View

13.

Nair J, van Staden J . Cytotoxic Agents in the Minor Alkaloid Groups of the Amaryllidaceae. Planta Med. 2021; 87(12-13):916-936. DOI: 10.1055/a-1380-1888. View

14.

Nair J, van Staden J, Bonneta S, Wilhelm A . Distribution and Diversity of Usage of the Amaryllidaceae in the Traditional Remediation of Infectious Diseases. Nat Prod Commun. 2018; 12(4):635-639. View

15.

Furst R . Narciclasine - an Amaryllidaceae Alkaloid with Potent Antitumor and Anti-Inflammatory Properties. Planta Med. 2016; 82(16):1389-1394. DOI: 10.1055/s-0042-115034. View

16.

Lamoral-Theys D, Andolfi A, Van Goietsenoven G, Cimmino A, Le Calve B, Wauthoz N . Lycorine, the main phenanthridine Amaryllidaceae alkaloid, exhibits significant antitumor activity in cancer cells that display resistance to proapoptotic stimuli: an investigation of structure-activity relationship and mechanistic insight. J Med Chem. 2009; 52(20):6244-56. PMC: 3205972. DOI: 10.1021/jm901031h. View

17.

Unver N, Irem Kaya G, Werner C, Verpoorte R, Gozler B . Galanthindole: a new indole alkaloid from Galanthus plicatus ssp. byzantinus. Planta Med. 2003; 69(9):869-71. DOI: 10.1055/s-2003-43206. View

18.

Nair J, van Staden J . Antifungal constituents of the plant family Amaryllidaceae. Phytother Res. 2018; 32(6):976-984. DOI: 10.1002/ptr.6049. View

19.

Jokhadze M, Eristavi L, Kutchukhidze J, Chariot A, Angenot L, Tits M . In vitro cytotoxicity of some medicinal plants from Georgian Amaryllidaceae. Phytother Res. 2007; 21(7):622-4. DOI: 10.1002/ptr.2130. View

20.

Ieven M, Van den Berghe D, Vlietinck A . Plant antiviral agents. IV. Influence of lycorine on growth pattern of three animal viruses. Planta Med. 1983; 49(2):109-14. View